僑雄國際(00381.HK)就成立合營簽諒解備忘 拓四川安老服務
僑雄國際(00381.HK)公布,於昨日(15日)全資附屬四川僑雄置業與綿陽了凡善德養老服務有限公司就可能於中國成立合營公司事項訂立諒解備忘錄。合營公司的註冊資本公司將以現金形式出資,將佔合營公司註冊資本的85%,綿陽了凡善德養老服務將以現金形式出資,將佔合營公司註冊資本的15%。
合營公司將命名為中商了凡健康醫療管理有限公司。初期公司將主要發展四川境內業務。經營範圍將會包括:建設開發生態農業、康養旅遊產業,打造田園綜合體;開發研製適老化科技產品,開發建設孝道、養生宣傳體驗基地;開發建設網上商城,構建健康管理平台。建設數家養老行業從業人員培訓基地,建設康復醫療基地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.